Detalhe da pesquisa
1.
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5-fluorouracil and leucovorin combination as first- or second-line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial.
Int J Cancer
; 148(10): 2512-2521, 2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33270911
2.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663264
3.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
4.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330065
5.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796151
6.
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Mod Pathol
; 28(11): 1481-91, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26449765
7.
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer.
Cancer
; 119(14): 2564-73, 2013 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633399
8.
[Alterations of thyroid function in cancer patients: a case of hypothyroidism during immunotherapy.] / Alterazioni della funzionalità tiroidea nel paziente oncologico: un caso di ipotiroidismo in corso di immunoterapia.
Recenti Prog Med
; 114(12): 14e-17e, 2023 Dec.
Artigo
em Italiano
| MEDLINE | ID: mdl-38031867
9.
A Prospective Study Evaluating Health-Related Quality of Life Following a Multimodal Treatment for Colorectal Cancer.
J Gastrointest Cancer
; 54(1): 117-125, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35075581
10.
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
J Exp Clin Cancer Res
; 42(1): 66, 2023 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932446
11.
Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.
Int J Cancer
; 131(11): 2684-92, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22488038
12.
Serological response to COVID-19 vaccination in patients with cancer older than 80 years.
J Geriatr Oncol
; 12(8): 1253-1255, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175246
13.
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Sci Rep
; 11(1): 13770, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215766
14.
Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab.
J Transl Med
; 8: 36, 2010 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20398370
15.
Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study.
Oncology
; 79(5-6): 415-22, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21474966
16.
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.
Cancer Med
; 9(12): 4148-4159, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32319740
17.
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
J Exp Clin Cancer Res
; 39(1): 279, 2020 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33302999
18.
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.
Clin Lung Cancer
; 20(4): 237-247.e1, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885550
19.
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Cancer Biol Ther
; 20(2): 192-200, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403909
20.
Tumor Regression Grade After Neoadjuvant Chemoradiation and Surgery for Low Rectal Cancer Evaluated by Multiple Correspondence Analysis: Ten Years as Minimum Follow-up.
Clin Colorectal Cancer
; 17(1): e13-e19, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28865674